Impact of Antabuse Treatment on Dyslipidemia and Oxidative Stress Levels in Chronic Alcoholism
Автор: Shanmugapriya V., Karthikeyan D., Ravish H., Srinivas H.
Журнал: Журнал стресс-физиологии и биохимии @jspb
Статья в выпуске: 4 т.16, 2020 года.
Бесплатный доступ
Background: Chronic alcoholics are known to have dyslipidemia, which can aggravate organ dysfunction along with increased oxidative stress due to alcohol metabolism. We are studying the impact of Antabuse treatment in reversing the damages caused by chronic alcoholism at metabolite level. Results: This is hospital based cross sectional case control study, with 34 chronic alcoholic patients and 20 Antabuse treated patient for alcoholism. The mean plasma MDA (oxidative stress marker) level among the chronic alcoholics was 12.3 ± 4.3 µmol/L and in Antabuse treated group was 2.8 ± 0.3 µmol/L. Chronic alcoholic group had significantly elevated lipid profile then Antabuse treated group suggesting dyslipidemia in alcoholic group in our study population. Discussion: We observed positive correlation between oxidative stress marker and Lipid profile. Dyslipidemia and oxidative stress levels were significantly lower in Antabuse treated patients suggesting early treatment of such addicts and complete abstinence from consumption showed reversal of the metabolic derangement caused by chronic alcoholism.
Alcoholism, Oxidative Stress, Dyslipidemia, Malondialdehyde, Disulfiram
Короткий адрес: https://sciup.org/143173868
IDR: 143173868
Список литературы Impact of Antabuse Treatment on Dyslipidemia and Oxidative Stress Levels in Chronic Alcoholism
- Das, S.K., and Vasudevan, D.M. (2005) Monitoring oxidative stress in patients with non-alcoholic and alcoholic liver diseases. Indian J. Clin. Biochem., 20, 24–28.
- Deshpande, N., Kandi, S., Kumar, P.B., Ramana, K.V., and Muddeshwar, M.G. (2013) Effect of Alcohol Consumption on Oxidative Stress Markers and its Role in the Pathogenesis and Progression of Liver Cirrhosis. American Journal of Medical and Biological Research., 1 (4), 99 -102.
- Esterbauer, H., Wäg, G., and Puhl, H. (1993) Lipid peroxidation and its role in atherosclerosis. Br. Med. Bull., 49, 566–576.
- Halliwell, B., Gutteridge, J.M., and Cross, C.E. (1992) Free radicals, antioxidants, and human disease: where are we now? J. Lab. Clin. Med., 119, 598–620.
- Harper, C., and Matsumoto, I. (2005) Ethanol and brain damage. Curr. Opin. Pharmacol., 5, 73–78.
- Huffman, J.C., and Stern, T.A. (2003) Disulfiram Use in an Elderly Man With Alcoholism and Heart Disease: A Discussion. Prim. Care Companion J. Clin. Psychiatry., 5, 41–44.
- Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., and Nishigaki, I. (2013) The vascular endothelium and human diseases. Int. J. Biol. Sci., 9, 1057–1069.
- Savolainen, V.T., Liesto, K., Männikkö, A., Penttilä, A., and Karhunen, P.J. (1993) Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. Alcohol. Clin. Exp. Res., 17, 1112–1117.
- Shanmugapriya, V., Mohanty, P.K., and Kumar, D.A. (2013) Association between body mass index, lipid peroxidation and coronary lipid risk factors in hypothyroid subjects. International journal of medical science and public health., 2( 4), 1063 – 1067
- Singh, M., Gupta, S., Singhal, U., Pandey, R., and Aggarwal, S.K. (2013) Evaluation of the Oxidative Stress in Chronic Alcoholics. J. Clin. Diagn. Res., 7, 1568–1571.
- Situnayake, R.D., Crump, B.J., Thurnham, D.I., Davies, J.A., Gearty, J., and Davis, M. (1990) Lipid peroxidation and hepatic antioxidants in alcoholic liver disease. Gut., 31, 1311–1317.
- Vasudevan D.M, Sreekumari S, Vaidyanathan K (2019) Textbook of Biochemistry for Medical Students. Ninth edition; Jaypee brothers medical publishers. New Delhi India. pp. 140 -141.
